{"id":"https://openalex.org/W2061762018","doi":"https://doi.org/10.1007/s10637-012-9922-7","title":"Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a Phase I multicentre trial in patients scheduled for elective breast cancer surgery","display_name":"Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a Phase I multicentre trial in patients scheduled for elective breast cancer surgery","publication_year":2013,"publication_date":"2013-01-12","ids":{"openalex":"https://openalex.org/W2061762018","doi":"https://doi.org/10.1007/s10637-012-9922-7","mag":"2061762018","pmid":"https://pubmed.ncbi.nlm.nih.gov/23315029"},"language":"en","primary_location":{"id":"doi:10.1007/s10637-012-9922-7","doi":"https://doi.org/10.1007/s10637-012-9922-7","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-012-9922-7","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071040536","display_name":"Nigel James Bundred","orcid":"https://orcid.org/0000-0001-6007-056X","observed_orcids":["https://orcid.org/0000-0001-6007-056X","https://orcid.org/0000-0002-5577-2345"]},"institutions":[{"id":"https://openalex.org/I4210150798","display_name":"Wythenshawe Hospital","ror":"https://ror.org/05vpsdj37","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210150798"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Nigel Bundred","raw_affiliation_strings":["Department of Academic Surgery, Education and Research Centre, University Hospital of South Manchester, Wythenshawe, M23 9LT Manchester, UK. bundredn@manchester.ac.uk","Department of Academic Surgery, Education and Research Centre, University Hospital of South Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Academic Surgery, Education and Research Centre, University Hospital of South Manchester, Wythenshawe, M23 9LT Manchester, UK. bundredn@manchester.ac.uk","institution_ids":["https://openalex.org/I4210150798"]},{"raw_affiliation_string":"Department of Academic Surgery, Education and Research Centre, University Hospital of South Manchester, Manchester, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077152126","display_name":"J\u0101nis Gardovskis","orcid":"https://orcid.org/0000-0001-9656-6209","observed_orcids":["https://orcid.org/0000-0001-9656-6209","https://orcid.org/0000-0002-7817-4268"]},"institutions":[{"id":"https://openalex.org/I4210126294","display_name":"Riga Stradi\u0146\u0161 University","ror":"https://ror.org/03nadks56","country_code":"LV","type":"education","lineage":["https://openalex.org/I4210126294"]}],"countries":["LV"],"is_corresponding":false,"raw_author_name":"Janis Gardovskis","raw_affiliation_strings":["Hereditary Cancer Institute, R\u012bga Stradi\u0146\u0161 University, R\u012bga, Latvia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hereditary Cancer Institute, R\u012bga Stradi\u0146\u0161 University, R\u012bga, Latvia","institution_ids":["https://openalex.org/I4210126294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037339560","display_name":"Janusz Ja\u015bkiewicz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75124487","display_name":"Gda\u0144sk Medical University","ror":"https://ror.org/019sbgd69","country_code":"PL","type":"education","lineage":["https://openalex.org/I75124487"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Janusz Jaskiewicz","raw_affiliation_strings":["Medical University of Gdansk, Gdansk, Poland","Medical University of Gda\u00f1sk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Gdansk, Gdansk, Poland","institution_ids":["https://openalex.org/I75124487"]},{"raw_affiliation_string":"Medical University of Gda\u00f1sk","institution_ids":["https://openalex.org/I75124487"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041246729","display_name":"J. Egl\u012btis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91123046","display_name":"University of Latvia","ror":"https://ror.org/05g3mes96","country_code":"LV","type":"education","lineage":["https://openalex.org/I91123046"]}],"countries":["LV"],"is_corresponding":false,"raw_author_name":"Janis Eglitis","raw_affiliation_strings":["Oncology Centre of Latvia, University of Latvia, Riga, Latvia","Univ. of Latvia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Centre of Latvia, University of Latvia, Riga, Latvia","institution_ids":["https://openalex.org/I91123046"]},{"raw_affiliation_string":"Univ. of Latvia","institution_ids":["https://openalex.org/I91123046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017500875","display_name":"V.V. Paramonov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Viktor Paramonov","raw_affiliation_strings":["Cherkassy Regional Oncology Centre, Cherkassy, Ukraine","Cherkassy Regional Oncology Centre"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cherkassy Regional Oncology Centre, Cherkassy, Ukraine","institution_ids":[]},{"raw_affiliation_string":"Cherkassy Regional Oncology Centre","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Peter McCormack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter McCormack","raw_affiliation_strings":["AstraZeneca, Macclesfield, UK","AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081130122","display_name":"Helen Swaisland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Helen Swaisland","raw_affiliation_strings":["AstraZeneca, Macclesfield, UK","AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041845055","display_name":"Maria Cavallin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maria Cavallin","raw_affiliation_strings":["AstraZeneca, Macclesfield, UK","AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074374578","display_name":"T. Parry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tony Parry","raw_affiliation_strings":["AstraZeneca, Macclesfield, UK","AstraZeneca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109902403","display_name":"James Carmichael","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James Carmichael","raw_affiliation_strings":["AstraZeneca, Macclesfield, UK","Celgene, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Celgene, Seville, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023041916","display_name":"J. Michael Dixon","orcid":"https://orcid.org/0000-0002-7583-331X","observed_orcids":["https://orcid.org/0000-0002-7583-331X"]},"institutions":[{"id":"https://openalex.org/I2800150677","display_name":"Western General Hospital","ror":"https://ror.org/009kr6r15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1324252669","https://openalex.org/I2800150677"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Michael Dixon","raw_affiliation_strings":["Breakthrough Research Unit, Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK","Western general Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breakthrough Research Unit, Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK","institution_ids":["https://openalex.org/I2800150677"]},{"raw_affiliation_string":"Western general Hospital","institution_ids":["https://openalex.org/I2800150677"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5071040536"],"corresponding_institution_ids":["https://openalex.org/I4210150798"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":5.7892,"has_fulltext":false,"cited_by_count":87,"citation_normalized_percentile":{"value":0.97237025,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"31","issue":"4","first_page":"949","last_page":"958"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":1.0},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8569999933242798},{"id":"https://openalex.org/keywords/breast-cancer-surgery","display_name":"breast cancer surgery","score":0.7300000190734863},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7549999952316284},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":1.0},{"id":"https://openalex.org/keywords/parp1-inhibition","display_name":"PARP1 inhibition","score":0.8999999761581421},{"id":"https://openalex.org/keywords/dose-finding","display_name":"dose-finding","score":0.7110000252723694},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.9779999852180481},{"id":"https://openalex.org/keywords/brca-mutations","display_name":"BRCA mutations","score":0.6880000233650208},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9789999723434448},{"id":"https://openalex.org/keywords/drug-exposure","display_name":"drug exposure","score":0.4009999930858612},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.8029999732971191}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.9681323766708374},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8296857476234436},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.8178046345710754},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7846063375473022},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5596625804901123},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5270025134086609},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5222195386886597},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5102767944335938},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5084025263786316},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.48159119486808777},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4299444556236267},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42518889904022217},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.41353151202201843},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39117833971977234},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33293431997299194},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.19540929794311523},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06863567233085632},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":true},{"descriptor_ui":"D003710","descriptor_name":"Demography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017558","descriptor_name":"Elective Surgical Procedures","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s10637-012-9922-7","doi":"https://doi.org/10.1007/s10637-012-9922-7","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-012-9922-7","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},{"id":"pmid:23315029","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23315029","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational new drugs","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1849059680","https://openalex.org/W1999659306","https://openalex.org/W2001673920","https://openalex.org/W2002962154","https://openalex.org/W2014035904","https://openalex.org/W2014599726","https://openalex.org/W2062568878","https://openalex.org/W2071997382","https://openalex.org/W2086038769","https://openalex.org/W2099455328","https://openalex.org/W2110017381","https://openalex.org/W2114197677","https://openalex.org/W2117964602","https://openalex.org/W2126247651","https://openalex.org/W2142658272","https://openalex.org/W2160466424","https://openalex.org/W2168169655","https://openalex.org/W2170176648","https://openalex.org/W2171972386","https://openalex.org/W3093265161"],"related_works":["https://openalex.org/W2071997382","https://openalex.org/W2946870784","https://openalex.org/W2171972386","https://openalex.org/W2895799603","https://openalex.org/W2921476638","https://openalex.org/W2786086629","https://openalex.org/W2997087259","https://openalex.org/W2903876972","https://openalex.org/W4328052893","https://openalex.org/W2905942070"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}